Calcium handling coupled to the endothelin ETA and ETB receptor-mediated vasoconstriction in resistance arteries: Differential regulation by PI3K, PKC and RhoK.

[1]  F. Perez-Vizcaino,et al.  Metabolic syndrome inhibits store-operated Ca2+ entry and calcium-induced calcium-release mechanism in coronary artery smooth muscle. , 2020, Biochemical pharmacology.

[2]  J. Ménard,et al.  Randomized Dose-Response Study of the New Dual Endothelin Receptor Antagonist Aprocitentan in Hypertension , 2020, Hypertension.

[3]  N. Sattar,et al.  Genetic dysregulation of endothelin-1 is implicated in coronary microvascular dysfunction , 2020, European heart journal.

[4]  J. Ménard,et al.  Pharmacological Characterization of Aprocitentan, a Dual Endothelin Receptor Antagonist, Alone and in Combination with Blockers of the Renin Angiotensin System, in Two Models of Experimental Hypertension , 2019, The Journal of Pharmacology and Experimental Therapeutics.

[5]  Ana Sanchez,et al.  Role of Phosphatidylinositol 3-Kinase (PI3K), Mitogen-Activated Protein Kinase (MAPK), and Protein Kinase C (PKC) in Calcium Signaling Pathways Linked to the α1-Adrenoceptor in Resistance Arteries , 2019, Front. Physiol..

[6]  Miguel López,et al.  Impaired Ca2+ handling in resistance arteries from genetically obese Zucker rats: Role of the PI3K, ERK1/2 and PKC signaling pathways , 2018, Biochemical pharmacology.

[7]  R. Khalil,et al.  Evolving mechanisms of vascular smooth muscle contraction highlight key targets in vascular disease. , 2018, Biochemical pharmacology.

[8]  R. Touyz,et al.  Vascular smooth muscle contraction in hypertension , 2018, Cardiovascular research.

[9]  R. Webb,et al.  High‐Salt Intake Augments the Activity of the RhoA/ROCK Pathway and Reduces Intracellular Calcium in Arteries From Rats , 2017, American journal of hypertension.

[10]  D. Webb,et al.  Smooth Muscle Endothelin B Receptors Regulate Blood Pressure but Not Vascular Function or Neointimal Remodeling , 2017, Hypertension.

[11]  C. Southan,et al.  Endothelin , 2016, Pharmacological Reviews.

[12]  L. Gaspers,et al.  Differential Regulation of Multiple Steps in Inositol 1,4,5-Trisphosphate Signaling by Protein Kinase C Shapes Hormone-stimulated Ca2+ Oscillations* , 2015, The Journal of Biological Chemistry.

[13]  M. Muñoz,et al.  Endothelin‐1 contributes to endothelial dysfunction and enhanced vasoconstriction through augmented superoxide production in penile arteries from insulin‐resistant obese rats: role of ETA and ETB receptors , 2014, British journal of pharmacology.

[14]  Ana Sanchez,et al.  Endothelial dysfunction, obesity and insulin resistance. , 2014, Current vascular pharmacology.

[15]  Michael J. Davis,et al.  Regulation of L-type calcium channel sparklet activity by c-Src and PKC-α. , 2013, American journal of physiology. Cell physiology.

[16]  Ana Sanchez,et al.  Impaired endothelin calcium signaling coupled to endothelin type B receptors in penile arteries from insulin-resistant obese Zucker rats. , 2013, The journal of sexual medicine.

[17]  Zachary P. Neeb,et al.  An Elevation in Physical Coupling of Type 1 Inositol 1,4,5-Trisphosphate (IP3) Receptors to Transient Receptor Potential 3 (TRPC3) Channels Constricts Mesenteric Arteries in Genetic Hypertension , 2012, Hypertension.

[18]  Toshio Kitazawa,et al.  Size‐dependent heterogeneity of contractile Ca2+ sensitization in rat arterial smooth muscle , 2012, The Journal of physiology.

[19]  C. Dessy,et al.  Different Effect of Rho Kinase Inhibition on Calcium Signaling in Rat Isolated Large and Small Arteries , 2012, Journal of Vascular Research.

[20]  N. Villalba,et al.  Impaired Ca2+ handling in penile arteries from prediabetic Zucker rats: involvement of Rho kinase. , 2011, American journal of physiology. Heart and circulatory physiology.

[21]  A. Ergul,et al.  Endothelial Endothelin B Receptor-Mediated Prevention of Cerebrovascular Remodeling Is Attenuated in Diabetes Because of Up-Regulation of Smooth Muscle Endothelin Receptors , 2011, Journal of Pharmacology and Experimental Therapeutics.

[22]  Z. Fortes,et al.  O-GlcNAcylation contributes to the vascular effects of ET-1 via activation of the RhoA/Rho-kinase pathway. , 2011, Cardiovascular research.

[23]  L. Capettini,et al.  Phosphatidylinositol 3‐kinase‐δ up‐regulates L‐type Ca2+ currents and increases vascular contractility in a mouse model of type 1 diabetes , 2010, British journal of pharmacology.

[24]  S. Watts,et al.  The interdependence of endothelin-1 and calcium: a review. , 2010, Clinical science.

[25]  J. Jaggar,et al.  Isoform-Selective Physical Coupling of TRPC3 Channels to IP3 Receptors in Smooth Muscle Cells Regulates Arterial Contractility , 2010, Circulation research.

[26]  Manuel F. Navedo,et al.  Elevated Ca2+ sparklet activity during acute hyperglycemia and diabetes in cerebral arterial smooth muscle cells. , 2010, American journal of physiology. Cell physiology.

[27]  C. Waters,et al.  IP3 Constricts Cerebral Arteries via IP3 Receptor–Mediated TRPC3 Channel Activation and Independently of Sarcoplasmic Reticulum Ca2+ Release , 2008, Circulation research.

[28]  N. Villalba,et al.  Rho kinase is involved in Ca2+ entry of rat penile small arteries. , 2008, American journal of physiology. Heart and circulatory physiology.

[29]  B. Callaghan,et al.  Role of L-type calcium channels and PKC in active tone development in rabbit coronary artery. , 2007, American journal of physiology. Heart and circulatory physiology.

[30]  W. Large,et al.  Endothelin‐1 activates a Ca2+‐permeable cation channel with TRPC3 and TRPC7 properties in rabbit coronary artery myocytes , 2007, The Journal of physiology.

[31]  N. Villalba,et al.  Contribution of both Ca2+ entry and Ca2+ sensitization to the alpha1-adrenergic vasoconstriction of rat penile small arteries. , 2007, American journal of physiology. Heart and circulatory physiology.

[32]  Markus P Schneider,et al.  Contrasting actions of endothelin ET(A) and ET(B) receptors in cardiovascular disease. , 2007, Annual review of pharmacology and toxicology.

[33]  L. Wold,et al.  Endothelin‐1 enhances oxidative stress, cell proliferation and reduces apoptosis in human umbilical vein endothelial cells: role of ETB receptor, NADPH oxidase and caveolin‐1 , 2005, British journal of pharmacology.

[34]  Mario Fritsch Neves,et al.  Endothelium-Restricted Overexpression of Human Endothelin-1 Causes Vascular Remodeling and Endothelial Dysfunction , 2004, Circulation.

[35]  R. Wetzker,et al.  Regulation of Vascular L-type Ca2 Channels by Phosphatidylinositol 3,4,5-Trisphosphate , 2004, Circulation research.

[36]  T. Masaki,et al.  Effects of phosphoinositide 3-kinase on endothelin-1-induced activation of voltage-independent Ca2+ channels and vasoconstriction. , 2004, Biochemical pharmacology.

[37]  A. Somlyo,et al.  Ca2+ sensitivity of smooth muscle and nonmuscle myosin II: modulated by G proteins, kinases, and myosin phosphatase. , 2003, Physiological reviews.

[38]  N. Sugimoto,et al.  Ca2+-Dependent Activation of Rho and Rho Kinase in Membrane Depolarization–Induced and Receptor Stimulation–Induced Vascular Smooth Muscle Contraction , 2003, Circulation research.

[39]  J. López-Barneo,et al.  Ca2+ channel‐sarcoplasmic reticulum coupling: a mechanism of arterial myocyte contraction without Ca2+ influx , 2003, The EMBO journal.

[40]  N. Morel,et al.  Rho‐dependent kinase is involved in agonist‐activated calcium entry in rat arteries , 2003, The Journal of physiology.

[41]  D. Hartshorne,et al.  Activation of RhoA and Inhibition of Myosin Phosphatase as Important Components in Hypertension in Vascular Smooth Muscle , 2003, Circulation research.

[42]  Z. Fortes,et al.  Gender differences in vascular expression of endothelin and ET(A)/ET(B) receptors, but not in calcium handling mechanisms, in deoxycorticosterone acetate-salt hypertension. , 2002, Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas.

[43]  T. Masaki,et al.  Effects of phosphoinositide 3-kinase on the endothelin-1-induced activation of voltage-independent Ca(2+) channels and mitogenesis in Chinese hamster ovary cells stably expressing endothelin(a) receptor. , 2002, Molecular pharmacology.

[44]  T. Masaki,et al.  Ca(2+) channels involved in endothelin-induced mitogenic response in carotid artery vascular smooth muscle cells. , 2002, American journal of physiology. Cell physiology.

[45]  E. Schiffrin.  Role of endothelin-1 in hypertension and vascular disease. , 2001, American journal of hypertension.

[46]  Z. Ungvari,et al.  Increased myogenic tone in skeletal muscle arterioles of diabetic rats. Possible role of increased activity of smooth muscle Ca2+ channels and protein kinase C. , 1999, Cardiovascular research.

[47]  T. Shimokama,et al.  Increased immunoreactivity of endothelin-1 and endothelin B receptor in human atherosclerotic lesions. A possible role in atherogenesis. , 1999, Atherosclerosis.

[48]  R. Cannon,et al.  Role of endothelin in the increased vascular tone of patients with essential hypertension. , 1999, Hypertension.

[49]  Emma J. Mickley,et al.  Activation of endothelin ETA receptors masks the constrictor role of endothelin ETB receptors in rat isolated small mesenteric arteries , 1997, British journal of pharmacology.

[50]  M. Maclean,et al.  EndothelinB receptor‐mediated contraction in human pulmonary resistance arteries , 1996, British journal of pharmacology.

[51]  E. Schiffrin,et al.  Endothelin subtype B receptor-mediated calcium and contractile responses in small arteries of hypertensive rats. , 1995, Hypertension.

[52]  T. Itoh,et al.  Mechanisms of vasoconstriction induced by endothelin‐1 in smooth muscle of rabbit mesenteric artery. , 1994, The Journal of physiology.

[53]  L. Edvinsson,et al.  Role of ERK/MAPK in endothelin receptor signaling in human aortic smooth muscle cells. , 2009, BMC cell biology.

[54]  R. Khalil,et al.  Endothelin-1--induced enhancement of coronary smooth muscle contraction via MAPK-dependent and MAPK-independent [Ca(2+)](i) sensitization pathways. , 2002, Hypertension.

[55]  S. Benedito,et al.  Endothelin-1-induced contraction of bovine retinal small arteries is reversible and abolished by nitrendipine. , 1991, Investigative ophthalmology & visual science.